Seroatlas · Human Serome Atlas

ZNF813

Zinc finger protein 813

Also known as: FLJ16542, ZN813_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q6ZN06
Gene
ZNF813
Ensembl
ENSG00000198346
Chromosome
19
Canonical length
617 aa
Protein class
Predicted intracellular proteins, Transcription factors
Subcellular location
Vesicles

OverviewNCBI Gene

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]

Canonical amino-acid sequenceUniProt

617 residues, UniProt reviewed canonical sequence.

>Q6ZN06|ZNF813
     1  MALPQGLLTF RDVAIEFSQE EWKCLDPAQR TLYRDVMLEN YRNLVSLDIS SKCMMKEFSS
    61  TAQGNREVIH TGTLQRHESH HTGDFRFQEI DKDIHNLEFQ WQEDERNSHE APMTEIKKLT
   121  GSADRYDQRH AGNKPIKDQL GSSFHSHLPE LHMFQTQGKI GNQVEKSIND ASSISTSQRI
   181  SCRPKTHISN NYGNNFRNSS LLTQKQEVHM REKSFQCNES GKAFNYSSLL RKHQIIHLGE
   241  KQYKCDVCGK VFNRKRNLVC HRRCHTGEKP YRCNECGKTF SQTYSLTCHR RLHTGEKPYK
   301  CEECDKAFSF KSNLKRHRRI HAGEKPYKCN ECGKTFSQTS SLTCHRRLHT GEKPFKCNEC
   361  GKTFSRKSSL TCHHRLHTGE KPYKCNECGK TFSQELTLKC HRRLHTGEKP YKCNECGKVF
   421  NKKANLARHH RLHSGEKPYK CTECVKTFSR NSALVIHKAI HIGEKRYKCN ECGKTFSRIS
   481  ALVIHTAIHT GEKPYKCNEC GKGFNRKTHL ACHHRLHTGE KPYKCNECGK VFNRKTHLAH
   541  HHRLHTGDKP YKCNECGKVF NQKAHLARHH RLHTGEKPYK CNECGKVFNQ KANLARHHRL
   601  HTGEKPYKFN ECGKAFN

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against ZNF813 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.47
Highest tissue expression
4.6 nTPM

Expression across tissuesHPA

Tissue

  • prostate: 4.6 nTPM
  • placenta: 3.4 nTPM
  • parathyroid gland: 2.2 nTPM
  • breast: 2.1 nTPM
  • lymph node: 2 nTPM
  • thymus: 2 nTPM

Single-cell type

  • prostatic glandular cells: 34 nCPM
  • extravillous trophoblasts: 32 nCPM
  • syncytiotrophoblasts: 30 nCPM
  • migrating cytotrophoblasts: 21 nCPM
  • cytotrophoblasts: 19 nCPM
  • pancreatic islet cells: 18 nCPM

Immune cell

  • NK-cell: 3.6 nTPM
  • non-classical monocyte: 3.1 nTPM
  • naive CD4 T-cell: 3 nTPM
  • naive B-cell: 2.4 nTPM
  • naive CD8 T-cell: 2.3 nTPM
  • memory CD8 T-cell: 1.9 nTPM

Brain region

  • white matter: 4.4 nTPM
  • medulla oblongata: 4 nTPM
  • midbrain: 4 nTPM
  • choroid plexus: 3.8 nTPM
  • pons: 3.8 nTPM
  • basal ganglia: 3.7 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.92
gnomAD pLI
0.64
gnomAD missense Z
-0.65
DepMap mean gene effect
0.07
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of ZNF813 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads ZNF813 as an antibody target. Whether an autoantibody or antibody against ZNF813 could matter depends on whether native ZNF813 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

ZNF813 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label ZNF813 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/ZNF813. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...